📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases. (2023)

First Author: Docherty CA

Attributed to: The Role of Cyclin-Dependent Kinase-9 Inhibition in Promoting the Resolution of Chronic Inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cti2.1455

PubMed Identifier: 37360982

Publication URI: http://europepmc.org/abstract/MED/37360982

Type: Journal Article/Review

Volume: 12

Parent Publication: Clinical & translational immunology

Issue: 6

ISSN: 2050-0068